Second, Hyperliquid introduced a token buyback mechanism that fundamentally improved its tokenomics. The program redirects 97–99% of the platform’s fee revenue toward HYPE token repurchases . A major piece of this revenue engine is a stablecoin deal with Circle and Coinbase that pulls roughly $80 million per year into the Hyperliquid ecosystem and routes the value to HYPE holders
. This creates consistent buy-side pressure, linking platform usage directly to token demand.
Third, and perhaps most significant for its novelty and downstream consequences, the protocol's HIP-3 framework went live with synthetic pre-IPO perpetual markets for major private companies. Traders can now gain synthetic exposure to SpaceX, Anthropic, and OpenAI — companies that have not yet gone public . The launch generated enormous attention and trading volume, and that activity spilled over directly into demand for HYPE, as the token is used for staking and governance within the platform
.
While the HIP-3 pre-IPO markets have fueled engagement, they have also placed Hyperliquid at the center of a brewing regulatory controversy. The core issue is that these contracts offer retail traders exposure to private company valuations without any actual equity ownership, in a market structure that operates entirely outside of U.S. securities laws.
These are synthetic perpetual futures contracts. Unlike the tokenized stock products that existed previously — many of which used special purpose vehicles (SPVs) to hold underlying shares — Hyperliquid's contracts involve zero actual equity . The “SPCX-USDC” SpaceX contract, for example, is a cash-settled derivative that tracks an implied share price for the company
. No shares change hands, and no company authorization is required. This is a critical legal distinction, but it is also the vulnerability. By design, these products circumvent the entire regulatory apparatus that governs traditional pre-IPO secondary markets, which require accredited investor status, full disclosure, and registered securities.
Matthew Pinnock, COO of Altura DeFi, told Decrypt that he expects regulators to “eventually scrutinize whether pre-IPO perpetual products function as unregistered securities exposure for retail traders” . Multiple market analysts echoed that concern, noting that while the HIP-3 model unlocks price discovery ahead of major tech IPOs, it “may attract regulatory scrutiny over potential unregistered securities exposure”
.
The companies themselves have already pushed back forcefully. OpenAI and Anthropic warned investors against trading tokenized stock products tied to their shares, stating that SPV-based share transfers are void . The tokenized products on platforms like PreStocks subsequently crashed roughly 50% after the companies’ statements, an event that serves as a clear precedent for the fragility of markets that lack the authorization of the underlying issuer
.
Because Hyperliquid is a decentralized exchange (DEX) with no central gatekeeper, there is no prospectus, no disclosure mandate, and no investor protection framework for these pre-IPO perpetuals . This regulatory gap has already attracted the early attention of traditional exchanges. Intercontinental Exchange and CME Group have reportedly urged the CFTC to address potential market integrity risks associated with the pseudonymous trading environment of platforms like Hyperliquid
. As more capital flows into synthetic pre-IPO markets, the likelihood of a coordinated response from the SEC or CFTC increases, making these products as risky from a compliance standpoint as they are innovative from a market-structure one.
Comments
0 comments